Proteasome inhibition reduces superantigen-mediated T cell activation and the severity of psoriasis in a SCID-hu model. [electronic resource]
Producer: 20020403Description: 671-9 p. digitalISSN:- 0021-9738
- Acetylcysteine -- analogs & derivatives
- Animals
- Antigens, CD -- metabolism
- Antigens, Differentiation, T-Lymphocyte -- metabolism
- Bacterial Toxins
- Cysteine Endopeptidases
- Cysteine Proteinase Inhibitors -- pharmacology
- DNA -- drug effects
- Disease Models, Animal
- Enterotoxins -- immunology
- HLA-DR Antigens -- metabolism
- Humans
- Lectins, C-Type
- Lymphocyte Activation -- drug effects
- Mice
- Mice, SCID
- Multienzyme Complexes -- antagonists & inhibitors
- NF-kappa B -- metabolism
- Proteasome Endopeptidase Complex
- Psoriasis -- drug therapy
- Receptors, Interleukin-2 -- metabolism
- Skin Transplantation -- immunology
- Superantigens -- metabolism
- T-Lymphocytes -- drug effects
- Transplantation, Heterologous
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.